Our laboratory demonstrated that the GLP-1R agonist liraglutide exerts neuroprotection in a PD mouse model by suppressing nigral inflammation and enhancing mitochondrial health via GLP-1R/PGC-1α signaling [19]. Here, GLP1R is linked to Parkinson disease.